Skip to content

Effect of Reduced Noise Levels and Cycled Light on Visual and Neural Development in Preterm Infants

Effect of Reduced Noise Levels and Cycled Light on Visual and Neural Development in Preterm Infants

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02688010
Enrollment
109
Registered
2016-02-23
Start date
2016-01-08
Completion date
2019-12-31
Last updated
2020-02-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Preterm Infants

Keywords

noise, sound, cycled light, preterm infants, neonatal care, growth, visual development

Brief summary

Noise is a hazard for newborn. In 1997, the American Academy of Pediatrics determined that safe sound levels in the neonatal intensive care unit (NICU) should not exceed 45 dB which has been rarely achieved. High intensities of noise have several negative effects on preterm newborns. Also, they are exposed to either continuous bright light continuous near darkness or unstructured combination of the two during their hospitalizations. The investigators primary objective is to determine the impact of reduced noise levels and cycled light on growth parameters and visual development in preterm infants.

Interventions

BEHAVIORALNoise reduction and cycled light

Reduced noise exposure (sound levels \<45 dB) and cycled light (approximately 12 hours of light on and 12 hours of light off).

Sponsors

Children's Hospital of Fudan University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
QUADRUPLE (Subject, Caregiver, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
1 Days to 7 Days
Healthy volunteers
No

Inclusion criteria

* \<37 gestational weeks preterm infants and \>1250g birth weight

Exclusion criteria

* Major congenital anomaly and infection prior to enrolment * Infants with surgical issues

Design outcomes

Primary

MeasureTime frameDescription
Flash visual evoked potentials (FVEP) at 4 weeks of ageat 4 weeks of ageFVEP is recorded from each eye individually after they fall asleep. Three silver-sliver chloride electrodes are placed according to 10-20 International system with active electrode at Oz (1-2 cm above inion), reference electrode at Fz and ground electrode at Cz. Scalp-electrode impedance is usually below 5kΩ but always below 10kΩ. Flash stimulus (2 Hz.) is given by light emitting diode goggles simulator at a distance of 2 cm to one eye at a time. 100 responses are averaged for each eye automatically in the Nicolet Viking Quest visual electrophysiological device at 1s total sweep time. Band pass filters are set at 0.1-75 Hz. The reproducibility of the responses is ensured by repeating the test two or more times. Responses with excessive artifacts are automatically rejected. The parameters of P1, N1, P2, N2, P3, and N3 of the FVEP are stored and subsequently assessed by ophthalmologist blinded to the infant's clinical course.
Bayley Scales of Infant Development, Second Edition (BSID-III) at 18 months of ageat 18 months of ageNeurodevelopment outcome is measured with the Bayley Scales of Infant Development, Second Edition (BSID-III) at corrected gestational age of 18 month, assessed by the physician from department of child health care who was blinded with respect to the subjects. Mental and motor scores were calculated by the BSID-III Mental Developmental Index (MDI) and Psychomotor Developmental Index (PDI). The subject's neurodevelopmental outcome was classified as delayed if either score was less than 70.

Secondary

MeasureTime frameDescription
Head circumferences at dischargeup to 3 months
Incidence of nosocomial infectionup to 3 months
Time to establish full enteral feedingbirth till discharge from hospital (up to 3 months)up to 3 months
Incidence of intraventricular hemorrhage1 month
Incidence of bronchopulmonary dysplasiaat corrected gestational age of 36 weeks
Incidence of retinopathy of prematurityup to 3 months
Weight at dischargebirth till discharge from hospital (up to 3 months)up to 3 months

Countries

China

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026